Liver and Brain Mucormycosis in a Diabetic Patient Type II Successfully Treated with Liposomial Amphotericin B

By Tsaousis George   Koutsouri Anastasia   Gatsiou Charoula   Paniara Olga   Peppas Christos   Chalevelakis George  

Scandinavian Journal of Infectious Diseases, Vol. 32, Iss. 3, 2000-10 ,pp. : 335-337

Informa Healthcare

Access to resources Recommend Favorite

Liposomal Amphotericin B and Surgery in the Successful Treatment of Invasive Pulmonary Mucormycosis in a Patient with Acute T-Lymphoblastic Leukemia

By Björkholm Magnus   Runarsson Gudmundur   Celsing Fredrik   Kalin Mats   Petrini Björn   Engervall Per  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 4, 2001-04 ,pp. : 316-319

Informa Healthcare

Access to resources Recommend Favorite

Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: Fluconazole, liposomal amphotericin B, caspofungin, and voriconazole

By Manfredi Roberto   Sabbatani Sergio  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 10, 2006-10 ,pp. : 950-951

Informa Healthcare

Access to resources Recommend Favorite

Biliary excretion of amphotericin B deoxycholate and amphotericin B lipid complex

By Duflo Frédéric   Allaouchiche Bernard   Chassard Dominique  

Scandinavian Journal of Infectious Diseases, Vol. 32, Iss. 5, 2000-11 ,pp. : 581-581

Informa Healthcare

Access to resources Recommend Favorite

Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden

By Naik Shalini   Lundberg Johan   Kumar Ritesh   Sjolin Jan   Jansen Jeroen P.  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 6-7, 2011-07 ,pp. : 504-514

Informa Healthcare

Access to resources Recommend Favorite